United Kingdom

People: Codexis Inc (CDXS.OQ)

CDXS.OQ on NASDAQ Stock Exchange Global Select Market

23 Jul 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Kelley, Bernard 

Mr. Bernard J. Kelley serves as an Independent Chairman of the Board of the Board of the Company effective November 29, 2016. He was Independent Director of Codexis, Inc., since April 2004. From 1993 to 2002, Prior to joining the Codexis Board, Mr. Kelley was President of the Merck Manufacturing Division where he was responsible for chemical, pharmaceutical and biological manufacturing and directed the activities of corporate engineering and global procurement. He also served as a member of the Merck Management Committee through his retirement in 2003. Mr. Kelley previously served as a Director of MAP Pharmaceuticals, Inc., a biotechnology company focused on developing inhalation-based therapies, as well as a Director of Aegis Analytical Corporation, an enterprise software company. He holds a B.S. in engineering from the U.S. Naval Academy.

Basic Compensation

Total Annual Compensation, USD 120,000
Restricted Stock Award, USD 84,995
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 204,995

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Bernard Kelley


John Nicols


Gordon Sangster


Laurie Heilmann


Thomas Baruch


Pam Cheng

As Of  31 Dec 2018